Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Hansha Must Deal with Generics from All Companies: Mr Eguchi of Seibu Sawai
February 25, 2008
- FY2008 Revision of Medical Fees Recommended by Chuikyo
February 25, 2008
- Premium of 4 Points to Be Paid to Heavy Generic Dispensers
February 25, 2008
- BUSINESS NEWS IN BRIEF
February 25, 2008
- Generics to Be NHI Price Listed in May and November from FY2009
February 25, 2008
- NHI Pricing Procedures to See Changes
February 25, 2008
- TOPICS／Poster Prepared by Korosho to Promote Use of Generics
February 25, 2008
- JPA Satisfied with Proposed Dispensing Fees: JPA Vice President
February 25, 2008
- Piecework System Should Be Applied to Drugs Used at Nursing Care Facilities
February 25, 2008
- MTX Recommended for Approval for JIA
February 25, 2008
- New System to Cover Certain Unapproved Medical Services by Insurance from April
February 25, 2008
- REGULATORY NEWS IN BRIEF
February 25, 2008
- 600 Points per Month for Managing Health of Elderly Patients
February 25, 2008
- JPMA to Study Clinical Trial Situation in Other Asian Countries
February 25, 2008
- MRI Using EOB Primovist Incorporates All Features of Conventional Methods
February 25, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 25, 2008
- Use of Standard Forms for Clinical Trial Documents
February 25, 2008
- Large-scale Databases Important for ADR Analysis
February 25, 2008
- Objection to Use of Literature by MRs without Obtaining Prior Consent
February 18, 2008
- REGULATORY NEWS IN BRIEF
February 18, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…